Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
The text messages motivate Christian Collins to keep inspiring others. One told the USC-bound forward about three family ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...
With a market cap of $112.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company focused on ...
About Sionna Therapeutics Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel ...
The agency has expanded the use of Alyftrek and Trikafta for treating patients with any genetic variant that results in production of CFTR proteins.
Precision Medicine Online and My Gene Counsel have partnered since 2019 on the "Genetic Testing Challenges" series to highlight real-world issues medical professionals are encountering as genetic ...
Superstring Capital Management acquired 180,593 shares of Sionna Therapeutics in the fourth quarter. The quarter-end position value rose by $7.43 million, reflecting the purchase of a new position.
LEXINGTON — In 1945, someone diagnosed with cystic fibrosis faced extremely long odds to live a long life. Many never made it out of childhood. Groundbreaking advances in research and care in recent ...
Cystic fibrosis used to be a death sentence. A progressive genetic disorder, the disease slowly drowned patients’ lungs with thick, sticky mucus while destroying other vital organs in its holistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results